Ophthalmology Volume 130, Number 7, July 2023
該文章描述了一個稱為「人工晶體植入症狀評估」（Assessment of IntraOcular Lens Implant Symptoms，AIOLIS）的病患報告的結果量表的開發，用於評估白內障手術和人工晶體植入手術相關的症狀。該研究遵循美國食品和藥物管理局（FDA）對於開發病患報告結果工具的建議。AIOLIS調查通過網上問卷調查、郵件追蹤和電話提醒向白內障手術患者進行調查。調查問題涵蓋了手術前後的視覺症狀和感知。結果顯示，手術後視覺症狀明顯減少，但黑色新月形影像(dark crescent-shaped shadows)的症狀除外。AIOLIS量表為評估臨床研究和臨床護理中的症狀和視覺感知提供了標準化的方法。該研究支持在評估白內障手術患者的人工晶體植入相關症狀和視覺感知時使用AIOLIS量表。
Development of a Patient-Reported Outcome Measure to Assess Symptoms
Associated with Cataract Surgery and Intraocular Lens Implants
The article describes the development of a patient-reported outcome measure called the Assessment of IntraOcular Lens Implant Symptoms (AIOLIS) to assess symptoms associated with cataract surgery and intraocular lens (IOL) implants. The study followed the recommendations of the FDA for developing patient-reported outcome instruments. The AIOLIS survey was administered to cataract surgery patients through web surveys with mail follow-up and phone reminders. The survey included questions about visual symptoms and perceptions before and after surgery. The results showed a significant decrease in symptoms after surgery, except for dark crescent-shaped shadows. Having monofocal IOL implants was associated with significantly more reduction in halos, starbursts, glare, and rings and spider webs, but less improvement in self-reported general vision.
The AIOLIS instrument provides a standardized way to assess symptoms and general perceptions of vision in clinical studies and clinical care. The study supports the use of the AIOLIS instrument in assessing symptoms and visual perceptions associated with IOL implants in cataract surgery patients.